Literature DB >> 28636714

Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus.

Renee Fruchter1, Drew J B Kurtzman2, Mital Patel2, Joseph Merola2, Andrew G Franks1, Ruth Ann Vleugels2, Alisa N Femia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28636714      PMCID： PMC5817470          DOI： 10.1001/jamadermatol.2017.1160

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  6 in total

1.  Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine.

Authors:  T Ruzicka; C Sommerburg; G Goerz; P Kind; H Mensing
Journal:  Br J Dermatol       Date:  1992-11       Impact factor: 9.302

2.  Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature.

Authors:  François Chasset; Camille Francès; Stéphane Barete; Zahir Amoura; Laurent Arnaud
Journal:  J Am Acad Dermatol       Date:  2015-01-30       Impact factor: 11.527

3.  Refractory subacute cutaneous lupus erythematous responding to a single course of belimumab: a new anti-BLyS human monoclonal antibody.

Authors:  Husein Husein-ElAhmed; Jose Luis Callejas-Rubio; Raquel Rios-Fernandez; Norberto Ortego-Centeno
Journal:  Indian J Dermatol Venereol Leprol       Date:  2014 Sep-Oct       Impact factor: 2.545

Review 4.  Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment.

Authors:  Emily Z Hejazi; Victoria P Werth
Journal:  Am J Clin Dermatol       Date:  2016-04       Impact factor: 7.403

5.  The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study.

Authors:  François Chasset; Laurent Arnaud; Nathalie Costedoat-Chalumeau; Noel Zahr; Didier Bessis; Camille Francès
Journal:  J Am Acad Dermatol       Date:  2016-02-03       Impact factor: 11.527

6.  Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients.

Authors:  Siamak Moghadam-Kia; Katherine Chilek; Elizabeth Gaines; Melissa Costner; Mathew E Rose; Joyce Okawa; Victoria P Werth
Journal:  Arch Dermatol       Date:  2009-03
  6 in total
  3 in total

1.  Successful treatment of two cases of refractory cutaneous lupus erythematosus with belimumab.

Authors:  Xavier Bosch-Amate; Daniel Morgado-Carrasco; Andrea Combalia; Priscila Giavedoni; Gerard Espinosa; José M Mascaró
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 May-Jun       Impact factor: 2.545

2.  In silico Analyses of Skin and Peripheral Blood Transcriptional Data in Cutaneous Lupus Reveals CCR2-A Novel Potential Therapeutic Target.

Authors:  Rama Dey-Rao; Animesh A Sinha
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

Review 3.  An update on the management of refractory cutaneous lupus erythematosus.

Authors:  Alice Verdelli; Alberto Corrà; Elena Biancamaria Mariotti; Cristina Aimo; Valentina Ruffo di Calabria; Walter Volpi; Lavinia Quintarelli; Marzia Caproni
Journal:  Front Med (Lausanne)       Date:  2022-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.